Vanessa Bloch

Dr. Vanessa Bloch

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 February 2003 in Nature Structural & Molecular Biology
Verified
Journal Article
Closed access
PDF file
VBVanessa Bloch
Vanessa Bloch
YYYinshan Yang
Yinshan Yang
EMEmmanuel Margeat
Emmanuel Margeat
ACAlain Chavanieu
Alain Chavanieu
MAMarie Thérèse Augé
Marie Thérèse Augé
MKMichel Kochoyan
Michel Kochoyan

24 January 2015 in Current Psychiatry Reports
Verified
Journal Article
Closed access
PDF file
FVFlorence VORSPAN
Florence VORSPAN
WMWajdi Mehtelli
Wajdi Mehtelli
GDGaël Dupuy
Gaël Dupuy
VBVanessa Bloch
Vanessa Bloch
JLJean-Pierre Lépine
Jean-Pierre Lépine

1 November 2003 in Journal of Molecular Biology
Verified
Journal Article
Closed access
RCRachel Cerdan
Rachel Cerdan
VBVanessa Bloch
Vanessa Bloch
YYYinshan Yang
Yinshan Yang
PBPhilippe Bertin
Philippe Bertin
CDChristian Dumas
Christian Dumas
SAStefan Arold
Stefan Arold

22 May 2015 in British Journal of Clinical Pharmacology
Verified
Journal Article
Closed access
PDF file
SMStéphane Mouly
Stéphane Mouly
VBVanessa Bloch
Vanessa Bloch
KPKatell Peoc'h
Katell Peoc'h
PHPascal Houze
Pascal Houze
Laurence LabatLaurence Labat
Laurence Labat
FVFlorence VORSPAN
Florence VORSPAN

1 December 2017 in Drug and Alcohol Dependence
Verified
Journal Article
Closed access
RIRomain Icick
Romain Icick
EKE. Karsinti
E. Karsinti
JLJ-P. Lépine
J-P. Lépine
VBVanessa Bloch
Vanessa Bloch
GBG. Brousse
G. Brousse
FVFlorence VORSPAN
Florence VORSPAN

28 October 2007 in Critical Care
Verified
Journal Article
Open access
PDF file
Bruno MégarbaneBruno Mégarbane
Bruno Mégarbane
NDNicolas Deye
Nicolas Deye
VBVanessa Bloch
Vanessa Bloch
RSRomain Sonneville
Romain Sonneville
CCCorinne Collet
Corinne Collet
FBFrédéric J Baud
Frédéric J Baud
Introduction: Prognostic factors in intentional insulin self-poisoning and the significance of plasma insulin levels are unclear. We therefore conducted this study to investigate prognostic factors in insulin poisoning, in relation to the value of plasma insulin concentration. Methods: We conducted a prospective study, and used logistic regression to explore prognostic factors and modelling to investigate toxicokinetic/toxicodynamic relationships. Results: Twenty-five patients (14 female and 11 male; median [25th to 75th percentiles] age 46 [36 to 58] years) were included. On presentation, the Glasgow Coma Scale score was 9 (4 to 14) and the capillary glucose concentration was 1.4 (1.1 to 2.3) mmol/l. The plasma insulin concentration was 197 (161 to 1,566) mIU/l and the cumulative amount of glucose infused was 301 (184 to 1,056) g. Four patients developed sequelae resulting in two deaths. Delay to therapy in excess of 6 hours (odds ratio 60.0, 95% confidence interval 2.9 to 1,236.7) and ventilation for longer than 48 hours (odds ratio 28.5, 95% confidence interval 1.9 to 420.6) were identified as independent prognostic factors. Toxicokinetic/toxicodynamic relationships between glucose infusion rates and insulin concentrations fit the maximum measured glucose infusion rate (Emax) model (Emax 29.5 [17.5 to 41.1] g/hour, concentration associated with the half-maximum glucose infusion rate [EC50] 46 [35 to 161] mIU/l, and R2 range 0.70 to 0.98; n = 6). Conclusion: Intentional insulin overdose is rare. Assessment of prognosis relies on clinical findings. The observed plasma insulin EC50 is 46 mIU/l.